Search Within

Robert Motzer

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (5)
  3. Research Letter (1)
Groups
  1. Department of Medicine (23)
  2. Genitourinary Oncology Service (23)
  3. Molecular Imaging and Therapy Service (23)
  4. Radiology, Department of (23)
  5. Solid Tumor Oncology Division (23)
  6. GSK Faculty (13)

More Groups

People
  1. Martin Voss (15)
  2. Chung-Han Lee (14)
  3. Darren Feldman (13)
  4. Cihan Duzgol (11)
  5. Steven Larson (10)
  6. Andrea Knezevic (9)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (5)
  4. 2022 (3)
  5. 2020 (2)
  6. 2019 (2)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of Nuclear Medicine (4)
  3. BMC Urology (1)
  4. CUAJ-Canadian Urological Association Journal (1)
  5. Cancer Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Society of Nuclear Medicine (4)
  3. American Association for Cancer Research (3)
  4. Biomed Central Ltd (1)
  5. Canadian Urological Association (1)
  6. Elsevier B.V. (1)

More Publishers

Results (23)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • An evaluation of the role of tumor load in cytoreductive nephrectomy
    Journal Article

    Silagy, A. W.; Duzgol, C.; Marcon, J.; DiNatale, R. G.; Mano, R.; Blum, K. A.; Reznik, E.; Voss, M. H.; Motzer, R. J.; Coleman, J. A.; more...
    CUAJ-Canadian Urological Association Journal (2020)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations
    Journal Article

    Ged, Y.; Gupta, R.; Duzgol, C.; Knezevic, A.; Shapnik, N.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    BMC Urology (2020)

    Fulltext@MSK | Save
  • Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents
    Meeting Abstract

    Ged, Y.; Lee, C. H.; Sanchez, A.; Duzgol, C.; Chaim, J.; Carlo, M. I.; Foster, A.; Akin, O.; Feldman, D. R.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF)
    Meeting Abstract

    Ged, Y.; Gupta, R.; Duzgol, C.; Shapnik, N.; Redzematovic, A.; Kotecha, R.; Voss, M. H.; Feldman, D. R.; Akin, O.; Patil, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Tumor xenografts of human clear cell renal cell carcinoma but not corresponding cell lines recapitulate clinical response to sunitinib: Feasibility of using biopsy samples
    Journal Article

    Dong, Y.; Manley, B. J.; Becerra, M. F.; Redzematovic, A.; Casuscelli, J.; Tennenbaum, D. M.; Reznik, E.; Han, S.; Benfante, N.; Chen, Y. B.; more...
    European Urology Focus (2017)

    Fulltext@MSK | Save
  • Genomic and metabolic characterization of succinate dehydrogenase B deficient renal cell carcinoma
    Meeting Abstract

    Lee, C. H.; Wei, E.; Lee, W.; Chen, Y.; Mano, R.; Hakimi, A. A.; Dong, Y.; Redzematovic, A.; Cross, J. R.; Tickoo, S.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • (124)I-cG250 PET scan for early detection of response to sunitinib in patients (Pts) with metastatic clear cell renal cell carcinoma (MccRCC)
    Meeting Abstract

    Larson, S. M.; Motzer, R. J.; Pandit-Taskar, N.; Bartz, R.; Feldman, D. R.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Phase I clinical trial with fractionated radioimmunotherapy using (131)I-labeled chimeric G250 in metastatic renal cancer
    Journal Article

    Divgi, C. R.; O'Donoghue, J. A.; Welt, S.; O'Neel, J.; Finn, R.; Motzer, R. J.; Jungbluth, A.; Hoffman, E.; Ritter, G.; Larson, S. M.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • Fractionated radioimmunotherapy with I-131-labeled chimeric antibody G250 (cG250) in patients with metastatic renal cell carcinoma
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D. A.; Motzer, R. J.; Anwar, K.; Sheikh, A.; Gonzalez, R. S.; Welt, S.; Old, L. J.; Larson, S. M.
    Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save
  • Fractionated radioimmunotherapy with I-131 chimeric antibody G250 (cG250) in metastatic renal cancer
    Meeting Abstract

    Divgi, C. R.; O'Donoghue, J. A.; McGagh, D.; Anwar, K.; Motzer, R.; Welt, S.; Larson, S. M.; Old, L. J.
    European Journal of Nuclear Medicine (1999)

    Fulltext@MSK | Save